Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism
Journal of Gastroenterology · 2024-04 · 59 (4) · 329-341
DOI: 10.1007/s00535-023-02075-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 24.01.2024. Verfasst von Isabel Cornejo-Pareja und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Campus Teatinos S/N, 29010, Málaga, Spain. i…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Gastrointestinal Microbiome, Obesity, Morbid. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Consejería de Salud y Consumo, Junta de Andalucía, Universidad de Málaga.
Abstract (Originalsprache)
Background/aim Alterations in gut microbiota are associated with the pathogenesis of metabolic diseases, including metabolic-associated fatty liver disease (MAFLD). The aim of this study was to evaluate gut microbiota composition and functionality in patients with morbid obesity with different degrees of MAFLD, as assessed by biopsy. Subjects/methods 110 patients with morbid obesity were evaluated by biopsy obtained during bariatric surgery for MAFLD. Stool samples were collected prior to surgery for microbiota analysis.
Results
Gut microbiota from patients with steatosis and non-alcoholic steatohepatitis (NASH) were characterized by an enrichment in Enterobacteriaceae (an ethanol-producing bacteria), Acidaminococcus and Megasphaera and the depletion of Eggerthellaceae and Ruminococcaceae (SCFA-producing bacteria). MAFLD was also associated with enrichment of pathways related to proteinogenic amino acid degradation, succinate production, menaquinol-7 (K2-vitamin) biosynthesis, and saccharolytic and proteolytic fermentation. Basic histological hepatic alterations (steatosis, necroinflammatory activity, or fibrosis) were associated with specific changes in microbiota patterns. Overall, the core microbiome related to basic histological alterations in MAFLD showed an increase in Enterobacteriaceae and a decrease in Ruminococcaceae . Specifically, Escherichia coli was associated with steatosis and necroinflammatory activity, whilst Escherichia-shigella was associated with fibrosis and necroinflammatory activity.
Conclusions
We established a link between gut microbiota alterations and histological injury in liver diagnosis using biopsy. Harmful products such as ethanol or succinate may be involved in the pathogenesis and progression of MAFLD. Thus, these alterations in gut microbiota patterns and their possible metabolic pathways could add information to the classical predictors of MAFLD severity and suggest novel metabolic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Campus Teatinos S/N, 29010, Málaga, Spain. isabelmaria.cornejo@gmail.com.
- Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND (IBIMA), Virgen de la Victoria University Hospital, Malaga University, 2ª Planta, Campus Teatinos S/N, 29010, Málaga, Spain. isabelmaria.cornejo@gmail.co…
- Centro de Investigacion Biomedica en Red de la Fisiopatología de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 29010, Málaga, Spain. isabelmaria.cornejo@gmail.com.
- Department of Medicine and Dermatology, Faculty of Medicine, University of Málaga, 29010, Málaga, Spain. isabelmaria.cornejo@gmail.com.
- Department of Medicine and Dermatology, Faculty of Medicine, University of Málaga, 29010, Málaga, Spain.
- Department of Clinical Analysis Laboratory, Virgen de la Victoria Hospital, 29010, Málaga, Spain.
Förderung
- Instituto de Salud Carlos III
- Consejería de Salud y Consumo, Junta de Andalucía
- Universidad de Málaga
Zitieren
APA
Cornejo-Pareja, I., Amiar, M. R., Ocaña-Wilhelmi, L., Soler-Humanes, R., Arranz-Salas, I., Garrido-Sánchez, L., Gutiérrez-Repiso, C., & Tinahones, F. J. (2024). Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism. Journal of Gastroenterology, 59(4), 329-341. https://doi.org/10.1007/s00535-023-02075-7
Vancouver
Cornejo-Pareja I, Amiar MR, Ocaña-Wilhelmi L, Soler-Humanes R, Arranz-Salas I, Garrido-Sánchez L, et al. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism. Journal of Gastroenterology. 2024;59(4):329-341. doi:10.1007/s00535-023-02075-7
BibTeX
@article{CornejoPareja2024,
author = {Cornejo-Pareja, Isabel and Amiar, Mohamed Reda and Ocaña-Wilhelmi, Luís and Soler-Humanes, Rocío and Arranz-Salas, Isabel and Garrido-Sánchez, Lourdes and Gutiérrez-Repiso, Carolina and Tinahones, Francisco Jose},
title = {Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism},
journal = {Journal of Gastroenterology},
year = {2024},
volume = {59},
number = {4},
pages = {329--341},
doi = {10.1007/s00535-023-02075-7}
}
EUVIMED